<div id="readability-page-1"><p>Sei Investments Co. lifted its stake in  Icon Plc (NASDAQ:ICLR - Free Report) by 104.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 606,227 shares of the medical research company's stock after buying an additional 309,635 shares during the period. Sei Investments Co. owned approximately 0.75% of Icon worth $88,176,000 as of its most recent filing with the Securities and Exchange Commission.</p><ul><li>3 Healthcare Pathbreakers With Long-Term Tailwinds</li></ul><p>Other large investors have also added to or reduced their stakes in the company. Artisan Partners Limited Partnership raised its holdings in  Icon by 67.4% in the 2nd quarter. Artisan Partners Limited Partnership now owns 7,184,870 shares of the medical research company's stock valued at $1,045,039,000 after acquiring an additional 2,893,946 shares in the last quarter.  Norges Bank acquired a new stake in shares of  Icon during the 2nd quarter worth $158,639,000.  1832 Asset Management L.P. increased its position in shares of  Icon by 587.9% in the second quarter. 1832 Asset Management L.P. now owns 1,151,328 shares of the medical research company's stock worth $167,461,000 after purchasing an additional 983,950 shares during the period.  Massachusetts Financial Services Co. MA raised its stake in  Icon by 21.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,752,008 shares of the medical research company's stock valued at $545,730,000 after purchasing an additional 650,379 shares in the last quarter.  Finally, Equity Investment Corp bought a new stake in  Icon during the second quarter worth about $82,264,000. Institutional investors and hedge funds own  95.61% of the company's stock. </p><h2>Wall Street Analyst Weigh In</h2><p>ICLR has been the subject of several analyst reports. Rothschild Redb upgraded shares of Icon from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Wednesday, September 3rd. Robert W. Baird  set a $220.00 price objective on shares of Icon in a research note on Friday, October 24th. Zacks Research upgraded shares of Icon from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, November 25th. Weiss Ratings  reaffirmed a &#34;hold (c-)&#34; rating on shares of Icon in a report on Monday, December 1st. Finally, Rothschild &amp; Co Redburn raised Icon from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and boosted their price target for the stock from $184.00 to $236.00 in a report on Wednesday, September 3rd. Two analysts have rated the stock with a Strong Buy rating, eight have issued  a Buy rating and ten have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company  has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $205.00.</p><ul><li>Should You Bring The Luck Of The Irish To Your Investmets?</li></ul><p><b>Read Our Latest Research Report on ICLR</b></p><h2>Icon Stock Performance</h2><p>NASDAQ ICLR opened at $189.93 on Friday. The firm's fifty day moving average price is $176.65 and its two-hundred day moving average price is $166.03. The stock has a market cap of $15.34 billion, a PE ratio of 25.70, a PEG ratio of 3.40 and a beta of 1.25. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.06 and a current ratio of 1.06. Icon Plc has a fifty-two week low of $125.10 and a fifty-two week high of $228.29. </p><h2>Icon Profile</h2> (Free Report)<p>ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Icon</li><li>How to Choose Top Rated Stocks</li><li>3 Recently Downgraded Stocks to Avoid in 2026</li><li>How to Invest in Blue Chip Stocks</li><li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li><li>3 Small Caps With Big Return Potential</li><li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li></ul><p><strong>Want to see what other hedge funds are holding ICLR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SUNMUg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Icon Right Now?</h2><p>Before you consider Icon, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Icon wasn't on the list.</p><p>While Icon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ICLR

<p>Sei Investments Co. increased its stake in Icon Plc by 104.4% in Q2, now owning 606,227 shares worth $88.18 million. Other major investors also raised their holdings. Icon's stock has a consensus rating of 'Moderate Buy' with a target price of $205.00. The stock opened at $189.93 on Friday with a market cap of $15.34 billion.</p>

Sei Investments Co. Acquires 309,635 Shares of Icon Plc $ICLR